Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2024-05-01
2024-07-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nocturnal Continuous Positive Airway Pressure in Chronic Obstructive Pulmonary Disease Patients
NCT02884830
Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD
NCT02285400
Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea
NCT03782844
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
NCT04084899
Validation and Reproducibility of the Six-minute Step Test in Individuals With Obstructive Sleep Apnea Treated With CPAP
NCT03334331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP treatment
CPAP treatment in COPD patients
Continuous Positive Airway Pressure
Patients with COPD were recruited to breath under the atmosphere pressure and different levels of CPAP (4, 6, 8 and 10 cm H2O).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Positive Airway Pressure
Patients with COPD were recruited to breath under the atmosphere pressure and different levels of CPAP (4, 6, 8 and 10 cm H2O).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Males and females, any race and aged 40-80 years
3. GOLD II-IV COPD (post-bronchodilator FEV1 \< 80 % of the predicted normal, and a post-bronchodilator FEV1/FVC \< 0.70)
Exclusion Criteria
2. Patients with concomitant pulmonary disease (e.g. lung fibrosis, interstitial lung disorder).
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State Key Laboratory of Respiratory Disease
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yuan-Ming Luo
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuanming Luo, PHD
Role: PRINCIPAL_INVESTIGATOR
Guangzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangzhou Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020 No.38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.